182 related articles for article (PubMed ID: 18593991)
41. Sex difference in diffuse malignant peritoneal mesothelioma.
Yan TD; Popa E; Brun EA; Cerruto CA; Sugarbaker PH
Br J Surg; 2006 Dec; 93(12):1536-42. PubMed ID: 17048277
[TBL] [Abstract][Full Text] [Related]
42. Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.
Yan TD; Boyer M; Tin MM; Sim J; Kennedy C; McLean J; Bannon PG; McCaughan BC
Ann Thorac Surg; 2009 May; 87(5):1552-6. PubMed ID: 19379903
[TBL] [Abstract][Full Text] [Related]
43. Targeting ALT: the role of alternative lengthening of telomeres in pathogenesis and prevention of cancer.
Bollmann FM
Cancer Treat Rev; 2007 Dec; 33(8):704-9. PubMed ID: 17933469
[TBL] [Abstract][Full Text] [Related]
44. Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms.
Johnson JE; Gettings EJ; Schwalm J; Pei J; Testa JR; Litwin S; von Mehren M; Broccoli D
Cancer Res; 2007 Oct; 67(19):9221-8. PubMed ID: 17909028
[TBL] [Abstract][Full Text] [Related]
45. Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma.
Ambrogi V; Mineo D; Gatti A; Pompeo E; Mineo TC
J Surg Oncol; 2009 Sep; 100(3):199-204. PubMed ID: 19274670
[TBL] [Abstract][Full Text] [Related]
46. Advances in the systemic therapy of malignant pleural mesothelioma.
Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
[TBL] [Abstract][Full Text] [Related]
47. The first molecular details of ALT in human tumor cells.
Muntoni A; Reddel RR
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317
[TBL] [Abstract][Full Text] [Related]
48. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
Yano H; Moran BJ; Cecil TD; Murphy EM
Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
[TBL] [Abstract][Full Text] [Related]
49. Telomere uncapping and alternative lengthening of telomeres.
Cesare AJ; Reddel RR
Mech Ageing Dev; 2008; 129(1-2):99-108. PubMed ID: 18215414
[TBL] [Abstract][Full Text] [Related]
50. Alternative lengthening of telomeres as a prognostic factor in malignant fibrous histiocytomas of bone.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2010 Dec; 30(12):4959-62. PubMed ID: 21187476
[TBL] [Abstract][Full Text] [Related]
51. Senescence mechanisms of nucleus pulposus chondrocytes in human intervertebral discs.
Kim KW; Chung HN; Ha KY; Lee JS; Kim YY
Spine J; 2009 Aug; 9(8):658-66. PubMed ID: 19540815
[TBL] [Abstract][Full Text] [Related]
52. Pathologic evaluation of malignant pleural mesothelioma.
Chirieac LR; Corson JM
Semin Thorac Cardiovasc Surg; 2009; 21(2):121-4. PubMed ID: 19822283
[TBL] [Abstract][Full Text] [Related]
53. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
Nakas A; Trousse DS; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Oct; 34(4):886-91. PubMed ID: 18656373
[TBL] [Abstract][Full Text] [Related]
54. Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?
Andersen M; Grauslund M; Muhammad-Ali M; Ravn J; Sørensen JB; Andersen CB; Santoni-Rugiu E
APMIS; 2012 Sep; 120(9):767-9. PubMed ID: 22882267
[No Abstract] [Full Text] [Related]
55. Evaluation of telomerase activity in non-genital Bowen's disease.
Mitsuishi T; Nakatake M; Kaneko T; Ohara K; Kato T; Iida K; Iwabu Y; Tokunaga K; Sata T; Kawana S; Yamada O
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):668-72. PubMed ID: 19250332
[TBL] [Abstract][Full Text] [Related]
56. Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms.
De Boeck G; Forsyth RG; Praet M; Hogendoorn PC
J Pathol; 2009 Feb; 217(3):327-44. PubMed ID: 19142887
[TBL] [Abstract][Full Text] [Related]
57. Mesothelioma: path to multimodality treatment.
Su S
Semin Thorac Cardiovasc Surg; 2009; 21(2):125-31. PubMed ID: 19822284
[TBL] [Abstract][Full Text] [Related]
58. The role of telomerase activity in psoriatic skin lesions.
Jurisic D; Kirin I; Rabic D; Dojcinovic B; Coklo M; Zamolo G
Med Hypotheses; 2007; 68(5):1093-5. PubMed ID: 17113716
[TBL] [Abstract][Full Text] [Related]
59. Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis, and aging.
Else T
J Mol Endocrinol; 2009 Oct; 43(4):131-41. PubMed ID: 19411304
[TBL] [Abstract][Full Text] [Related]
60. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy.
Arrossi AV; Lin E; Rice D; Moran CA
Am J Clin Pathol; 2008 Nov; 130(5):754-64. PubMed ID: 18854268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
